Literature DB >> 28855139

The effect of an acute systemic inflammatory insult on the chronic effects of a single mild traumatic brain injury.

Lyndsey E Collins-Praino1, Alina Arulsamy1, Viythia Katharesan1, Frances Corrigan2.   

Abstract

A small but significant proportion of mild traumatic brain injury (mTBI) sufferers will report persistent symptoms, including depression, anxiety and cognitive deficits, in the months, or even years, following the initial event. This is known as post-concussion syndrome and its pathogenesis is not yet known. This study sought to investigate the role of a peripheral inflammatory insult in the development of ongoing behavioral symptoms following a mTBI. To investigate, male Sprague-Dawley rats were administered a single mTBI using the diffuse impact-acceleration model to generate ∼100G of force. Sham animals underwent surgery only. At 5days following surgery, rats were given either the TLR4 agonist, lipopolysaccharide (LPS, 0.1mg/kg), or saline via an intraperitoneal injection. mTBI animals showed an exaggerated response to LPS, with an increase in the expression of pro-inflammatory cytokines within the hippocampus at 24h post-dose, an effect not seen in sham animals. This was associated with the development of persistent behavioral deficits in the mTBI:LPS animals at 3 months post-injury. These behavioral deficits consisted of increased time spent immobile on the forced swim-test, indicative of depressive like behavior, impaired cognitive performance on the Barnes Maze and decreased anxiety on the Elevated Plus Maze. In contrast, animals administered mTBI alone had no deficits. This study provides evidence that a peripheral inflammatory stimulus can facilitate ongoing symptoms following a mTBI. As such this provides a basis for further exploration of exogenous factors which promote immune system activation as potential targets for intervention to allow the resolution of symptoms following a mTBI. Crown
Copyright © 2017. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognition; Depression; Inflammation; Post-concussion syndrome; mTBI

Mesh:

Substances:

Year:  2017        PMID: 28855139     DOI: 10.1016/j.bbr.2017.08.035

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  16 in total

1.  Transcranial low-frequency pulsating electromagnetic fields (T-PEMF) as post-concussion syndrome treatment.

Authors:  Claire Prener Miller; Martin Prener; Steen Dissing; Olaf B Paulson
Journal:  Acta Neurol Scand       Date:  2020-07-16       Impact factor: 3.209

Review 2.  Inflammation in Traumatic Brain Injury.

Authors:  Teodor T Postolache; Abhishek Wadhawan; Adem Can; Christopher A Lowry; Margaret Woodbury; Hina Makkar; Andrew J Hoisington; Alison J Scott; Eileen Potocki; Michael E Benros; John W Stiller
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Lipopolysaccharide worsens the prognosis of experimental cerebral ischemia via interferon gamma-induced protein 10 recruit in the acute stage.

Authors:  Ping Wang; Jiaqi Zhang; Feifei Guo; Shuang Wang; Yi Zhang; Defeng Li; Haiyu Xu; Hongjun Yang
Journal:  BMC Neurosci       Date:  2019-12-27       Impact factor: 3.288

4.  Choice-based assessments outperform traditional measures for chronic depressive-like behaviors in rats after brain injury.

Authors:  Michelle Frankot; Christopher O'Hearn; Cole Vonder Haar
Journal:  Behav Brain Res       Date:  2020-08-22       Impact factor: 3.332

5.  Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients.

Authors:  Christopher Duma; Oleg Kopyov; Alex Kopyov; Mark Berman; Elliot Lander; Michael Elam; Michael Arata; David Weiland; Ruslana Cannell; Chad Caraway; Sean Berman; Kristin Scord; Lian Stemler; Karlyssa Chung; Samuel Khoudari; Rory McRory; Chace Duma; Sawyer Farmer; Anthony Bravo; Christian Yassa; Ami Sanathara; Elisa Singh; Benjamin Rapaport
Journal:  Mol Biol Rep       Date:  2019-07-20       Impact factor: 2.316

Review 6.  The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer's Disease.

Authors:  Olga N Kokiko-Cochran; Jonathan P Godbout
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

Review 7.  Catastrophic consequences: can the feline parasite Toxoplasma gondii prompt the purrfect neuroinflammatory storm following traumatic brain injury?

Authors:  Tamara L Baker; Mujun Sun; Bridgette D Semple; Shiraz Tyebji; Christopher J Tonkin; Richelle Mychasiuk; Sandy R Shultz
Journal:  J Neuroinflammation       Date:  2020-07-25       Impact factor: 8.322

8.  Minocycline blocks traumatic brain injury-induced alcohol consumption and nucleus accumbens inflammation in adolescent male mice.

Authors:  Kate Karelina; Samuel Nicholson; Zachary M Weil
Journal:  Brain Behav Immun       Date:  2018-02-01       Impact factor: 7.217

9.  Thrombin Inhibition Reduces the Expression of Brain Inflammation Markers upon Systemic LPS Treatment.

Authors:  Efrat Shavit Stein; Marina Ben Shimon; Avital Artan Furman; Valery Golderman; Joab Chapman; Nicola Maggio
Journal:  Neural Plast       Date:  2018-06-19       Impact factor: 3.599

10.  A Systematic Review of Closed Head Injury Models of Mild Traumatic Brain Injury in Mice and Rats.

Authors:  Colleen N Bodnar; Kelly N Roberts; Emma K Higgins; Adam D Bachstetter
Journal:  J Neurotrauma       Date:  2019-03-06       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.